TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
10x Genomics Sweden AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
23,030
|
15,565
|
7,732 |
| Financial expenses |
1
|
1
|
84 |
| Earnings before taxes |
12,206
|
7,371
|
2,366 |
| EBITDA |
13,062
|
7,645
|
2,854 |
| Total assets |
23,400
|
13,263
|
6,514 |
| Current assets |
20,864
|
10,610
|
4,602 |
| Current liabilities |
5,051
|
3,830
|
2,901 |
| Equity capital |
18,349
|
9,432
|
3,613 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
45
|
38
|
20 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
78.4%
|
71.1%
|
55.5% |
| Turnover per employee |
512
|
410
|
387 |
| Profit as a percentage of turnover |
53.0%
|
47.4%
|
30.6% |
| Return on assets (ROA) |
52.2%
|
55.6%
|
37.6% |
| Current ratio |
413.1%
|
277.0%
|
158.6% |
| Return on equity (ROE) |
66.5%
|
78.1%
|
65.5% |
| Change turnover |
8,726
|
7,976
|
3,099 |
| Change turnover % |
61%
|
105%
|
67% |
| Chg. No. of employees |
7
|
18
|
12 |
| Chg. No. of employees % |
18%
|
90%
|
150% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.